Abstract 2071P
Background
The objective of this study is to identify the major issues and concerns of cancer patients in Korea related to cancer, anti-cancer therapy, and patient care that are mentioned on social media.
Methods
We collected data from open-access forums, blogs, and social networking sites using professional ISO 20252 certified online access tools. We searched the terms “cancer”, "cancer treatment", and “patient care” and collected social media posts between October 2021 and September 2022, excluding spam and advertisements.
Results
Total 169,575 social media posts were collected. Among the posts, 51% were related to cancer symptoms, concerns following diagnosis, and cancer etiology, while 39% discussed treatment methods, treatment-related side effects, novel therapies, as well as costs. The remaining posts centered on how to manage in daily life. The most frequently mentioned cancer types were breast, lung, colorectal, stomach, and liver cancer, consistent with common cancers in Korea. Concerning the difficulties experienced, 52% reported physical challenges, 42% reported emotional challenges, and 6% discussed daily life issues, such as diet and sexual relationships. Additionally, patients had high expectations for immune checkpoint inhibitors. Patients tend to view clinical trial participation as an alternative when conventional treatments are ineffective and see it positively as a way to participate without financial burden. However, some express safety concerns. Patients frequently shared tips for managing daily life on social media, such as healthy eating, taking supplements, and light exercise to maintain physical strength.
Conclusions
Our findings suggest that cancer patients in Korea frequently use social media for information. The high frequency of emotional difficulties mentioned indicates that patients face persistent emotional challenges throughout the cancer journey. This study underscores the potential benefits of analyzing social media posts by cancer patients, providing valuable insights for healthcare professionals and patients. Moreover, it emphasizes the importance of the developing and delivering professional information on daily life management for cancer patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Korean Society of Medical Oncology.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2106P - Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer
Presenter: Amy Body
Session: Poster session 06
2107P - Thromboprophylaxis with intermediate or prophylactic doses of LMWHs in ambulatory cancer patients
Presenter: Nikolaos Tsoukalas
Session: Poster session 06
2108P - Vitamin B12 and its clinical relevance in hospitalized cancer patients
Presenter: Stefano Maccarone
Session: Poster session 06
2109P - Vitamin A, D and E levels in patients with solid tumors undergoing palliative systemic cancer treatment
Presenter: Julia Berger
Session: Poster session 06
2111P - The value of multiple psychometric tools for distress screening and referral in a cancer population
Presenter: Daniel Anderson
Session: Poster session 06
2112P - Initial geriatric assessment and chemotherapy tolerability treatment in Brazilian patients with malignant neoplasm of the digestive system
Presenter: Marcos Dumont Bonfin Santos
Session: Poster session 06
2113P - Efficacy and effectiveness of prophylactic magnesium supplementation on prevention of cisplatin-induced nephrotoxicity: A systematic review and meta-analysis
Presenter: Caio Castro
Session: Poster session 06
2114P - Impact of comprehensive geriatric assessment (CGA) in the management of chemotherapy toxicity in older cancer patients
Presenter: Jordi Recuero-Borau
Session: Poster session 06
2115P - Pre-cachexia incidence in patients with solid cancer: A cross-sectional study
Presenter: Lynn Gottmann
Session: Poster session 06